With more people facing cancer and needing organ transplants, it is important to understand where the disease originates from, how it develops, how it can be treated and how to diagnose it in the most effective, but the least invasive manner possible.
The MOPS team conducts research on the development of modern methods for minimally invasive sampling and advanced multiomics analysis to advance personalized medicine.
The focus mainly lies on applications in oncology and transplant medicine, where the ability to monitor molecular changes in a minimally invasive manner is crucial for diagnosis, assessing treatment efficacy, and monitoring patient condition. By developing models within an experimental framework, the research team aims to translate their findings from in vitro and in vivo laboratory models into various clinical applications.
